Consolidated Statements of Cash Flows

Years ended March 31

(amounts in millions of Canadian dollars)

 

2007

 

2006

 

2005

Operating Activities

 

 

 

Restated

 

Restated

 

 

 

(Note 1)

 

(Note 1)

Net earnings (loss)

$

127.4

$

63.6

$

(199.6)

Results of discontinued operations (Note 4)

 

1.7

 

6.0

 

(104.8)

Earnings (loss) from continuing operations

 

129.1

 

69.6

 

(304.4)

Adjustments to reconcile earnings to cash flows from operating activities:

 

 

 

 

 

 

Impairment of goodwill, tangible and intangible assets (Note 5)

 

 

 

443.3

Depreciation

 

55.0

 

52.5

 

55.1

Amortization of deferred financing costs

 

0.8

 

2.2

 

7.2

Amortization and write down of intangible and other assets

 

15.8

 

22.9

 

19.7

Future income taxes

 

(14.2)

 

5.1

 

(114.1)

Investment tax credits

 

19.3

 

(11.8)

 

(29.2)

Stock-based compensation plans (Note 17)

 

24.6

 

12.2

 

5.5

Employee future benefit – net

 

(0.9)

 

(2.0)

 

0.9

Other

 

(10.4)

 

(3.9)

 

11.2

Changes in non-cash working capital (Note 19)

 

20.2

 

79.1

 

84.2

Net cash provided by continuing operating activities

 

239.3

 

225.9

 

179.4

Net cash provided by discontinued operating activities

 

 

2.1

 

21.6

Net cash provided by operating activities

 

239.3

 

228.0

 

201.0

Investing Activities

 

 

 

 

 

 

Business acquisitions (net of cash and cash equivalents acquired) (Note 2)

 

(4.4)

 

2.6

 

(13.8)

Proceeds from disposal of discontinued operations

 

(3.8)

 

 

 

 

(net of cash and cash equivalents disposed) (Note 4, 19)

 

 

(4.9)

 

239.4

Capital expenditures

 

(158.1)

 

(130.1)

 

(118.0)

Proceeds from sale and leaseback of assets

 

 

 

43.8

Deferred development costs

 

(3.0)

 

(1.8)

 

(9.9)

Deferred pre-operating costs

 

(5.9)

 

(0.7)

 

(1.7)

Other

 

(2.9)

 

( 9.9)

 

4.2

Net cash (used in) provided by continuing investing activities

 

(178.1)

 

(144.8)

 

144.0

Net cash used in discontinued investing activities

 

 

(2.3)

 

(5.8)

Net cash (used in) provided by investing activities

 

(178.1)

 

(147.1)

 

138.2

Financing Activities

 

 

 

 

 

 

Net borrowing under revolving unsecured credit facilities (Note 12)

 

(0.6)

 

(30.7)

 

(273.7)

Proceeds from long-term debt (Note 12)

 

45.8

 

32.1

 

3.4

Reimbursement of long-term debt (Note 12)

 

(39.8)

 

(65.7)

 

(50.5)

Dividends paid

 

(9.8)

 

(9.7)

 

(24.0)

Common stock issuance (Note 15)

 

10.0

 

8.0

 

3.6

Other

 

(2.1)

 

11.6

 

0.7

Net cash provided by (used in) continuing financing activities

 

3.5

 

(54.4)

 

(340.5)

Net cash provided by discontinued financing activities

 

 

1.2

 

3.2

Net cash provided by (used in) financing activities

 

3.5

 

(53.2)

 

(337.3)

Effect of foreign exchange rate changes on cash and cash equivalents

 

4.4

 

(8.1)

 

(2.3)

Net increase (decrease) in cash and cash equivalents

 

69.1

 

19.6

 

(0.4)

Cash and cash equivalents at beginning of year

 

81.1

 

61.5

 

61.9

Cash and cash equivalents at end of year

$

150.2

$

81.1

$

61.5

Cash and cash equivalents related to:

 

 

 

 

 

 

Continuing operations

$

150.2

$

81.1

$

57.1

Discontinued operations (Note 4)

 

 

 

4.4

 

$

150.2

$

81.1

$

61.5

Supplementary Cash Flows Information (Note 19)

The accompanying notes form an integral part of these Consolidated Financial Statements.